-
-
28/11/2023 29/11/2023 America/Toronto Life Sciences IP Due Diligence Life Sciences IP Due Diligence
November 28 – 29, 2023
The Westin Copley Place, Boston, MA
Please visit https://www.americanconference.com/life-sciences-ip-due-diligence/ for more information and updates. The Westin Copley Place, Boston, MA true DD/MM/YYYY 1440 use-title -
-
-
28/11/2023 29/11/2023 America/Toronto Life Sciences IP Due Diligence Life Sciences IP Due Diligence
November 28 – 29, 2023
The Westin Copley Place, Boston, MA
Please visit https://www.americanconference.com/life-sciences-ip-due-diligence/ for more information and updates. The Westin Copley Place, Boston, MA true DD/MM/YYYY 1440 use-title -
Anti-Trust Enforcement in the Life Sciences: Examining Impact, Trends and Best Practices for Incorporating Anti-Trust into Your IP Due Diligence Checklist
Samantha R. Morelli
Partner
Kirkland & Ellis LLP
Kevin Noonan, Ph.D.
Partner | Co-Chair Biotechnology and Pharmaceuticals Practice Group
McDonell Boehnen Hulbert & Berghoff LLP
Since 2022, the FTC and anti-trust division of the DOJ have been increasingly investigating and challenging M&A in the life sciences: the proposed Optum-Amedisys deal; Amgen-Horizon; PfizerSeagen; and Merck-Prometheus, to name a few. This session will explore the anti-trust concerns from these cases and extrapolate their impact on IP due diligence and deal-making for the future.